Condition
Advanced Nonhaematologic Malignancies
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 2 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
2 shownSafety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered TumorsNCT03780517 · 2018-12-12
COMPLETEDStudy of Paclitaxel in Combination With BOS172722 in Patients With Advanced Nonhaematologic MalignanciesNCT03328494 · 2017-10-13
COMPLETEDCommon interventions
Leading sponsors
Trial status mix
COMPLETED2
Phase mix
PHASE12
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.